1. Home
  2. Angel / Venture

Category: life science

Oxford University investment partner OSE raises £250m to back groundbreaking next-gen science startups

University of Oxford-partnering investment firm Oxford Science Enterprises has raised £250m to drive the creation and growth of businesses built on ground-breaking science from the hallowed institution. The post Oxford University investment partner OSE raises

Forbion holds €470m first close for Growth Opp Fund II, expects €600m hard cap close in Summer

European life science venture capital firm Forbion has held a first close of a €470m fund to invest in late-stage European life science companies.  The post Forbion holds €470m first close for Growth Opp Fund

New B2B life science investor Biospring Partners brings in $245m for debut fund

Newly-found B2B life science investor Biospring Partners has closed its debut fund and co-investment vehicles with north of $245m in capital commitments. The post New B2B life science investor Biospring Partners brings in $245m for

Cathay Capital launches €500m health fund for tech-enabled healthcare, life science investments

Cathay Capital has launched a new €500m health fund to invest in healthcare, life sciences and technology. The post Cathay Capital launches €500m health fund for tech-enabled healthcare, life science investments first appeared on AltAssets

NovaQuest strikes $500m hard cap for latest life science, pharma services-focused private equity fund

NovaQuest Capital Management has struck a $500m hard cap close for its latest private equity investment fund. The post NovaQuest strikes $500m hard cap for latest life science, pharma services-focused private equity fund first appeared

Cambridge Innovation Capital raises £225m for deeptech, life science investments

Cambridge Innovation Capital, the venture capital investor founded to improve the success rate of deeptech and life sciences businesses originating from the University of Cambridge, has raised £225m for its second fund. The post Cambridge

5AM Ventures ups fundraising ante with $750m across new flagship, later-stage funds

Biopharma, medical tech and life sciences-focused 5AM Ventures has raised $750m across a new pair of funds targeting startups across the early and late-stage of investment. The post 5AM Ventures ups fundraising ante with $750m

Veteran life science investor Pappas Capital eyes up to $250m for sixth fund

Life sciences investor Pappas Capital is in the market for up to $250m of new capital through its Fund VI raise - double the total it hoped to gather for its previous fund. The post

Blackstone Growth leads financing round in biomedical data analysis software DNAnexus

Blackstone Growth has led a $200m financing round in cloud-based biomedical data analysis software DNAnexus. The post Blackstone Growth leads financing round in biomedical data analysis software DNAnexus first appeared on AltAssets Private Equity News.

Carlyle sells Thomas Scientific to Broad Sky Partners after successful bolt-on push, market expansion

Global buyout giant Carlyle has sold life science industry equipment and supplies provider Thomas Scientific to Broad Sky Partners. The post Carlyle sells Thomas Scientific to Broad Sky Partners after successful bolt-on push, market expansion

CDPQ takes stake in supply chain testing, inspection business QIMA

Institutional investment major Caisse de dépôt et placement du Québec has picked up a significant minority interest in QIMA, a provider of supply chain compliance solutions. The post CDPQ takes stake in supply chain testing,

NovaQuest Capital picks up TechAccel stake in Covenant Animal Health Partners

Bioscience and life sciences investor NovaQuest Capital Management has bought TechAccel's stake in Covenant Animal Health Partners. The post NovaQuest Capital picks up TechAccel stake in Covenant Animal Health Partners first appeared on AltAssets Private

Advent International to buy €1bn-generating chemical producer Caldic from Goldman Sachs AM

Global buyout major Advent International  has agreed to acquire €1bn-generating life sciences and specialty chemical producer Caldic BV from Goldman Sachs AM. Caldic will be merged with Advent portfolio company Latin American chemical distributor Grupo

EQT to buy €2.2bn-managing life science VC firm LSP for €450m

Buyout giant EQT has agreed to buy into €2.2bn-managing European life science venture capital firm LSP for €450m to strengthen its position in the healthcare sector. A potential earn-out payment of €25m will also be

Bain Capital joins Polaris to back cardiovascular treatment developer Cardurion in $300m deal

Bain Capital has made a $300m investment in Polaris-backed Cardurion Pharmaceuticals through Bain Capital Life Sciences and Bain Capital Private Equity. The post Bain Capital joins Polaris to back cardiovascular treatment developer Cardurion in $300m

$1.1bn-managing Sverica buys into system integration firm Control Concepts

Sverica Capital Management has bought into system integration firm Control Concepts. The post $1.1bn-managing Sverica buys into system integration firm Control Concepts first appeared on AltAssets Private Equity News.

ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer Xpress Biologics

Healthcare-focused buyout house ArchiMed has bought into Belgium-based Xpress Biologics to finance a 10x expansion of its production capacity, the firm said. The post ArchiMed looks to replicate impressive Polyplus success with investment in DNA producer

Advent France Biotechnology holds €86m first close for Fund II amid ‘huge, unmet need’ for early life sciences financing

Advent France Biotechnology has held an €86m first close for its second fund, already surpassing the size of its debut vehicle in the strategy. The post Advent France Biotechnology holds €86m first close for Fund

Italy’s Panakès Partners hires industry veteran Rob Woodman to lead new biotech investment team

Italian life sciences investor Panakès Partners has hired Rob Woodman as partner to lead the firm’s newly created biotech investment team. The post Italy’s Panakès Partners hires industry veteran Rob Woodman to lead new biotech

BGV hires veteran pair to boost life science investment expertise

Early-stage European biopharma investment specialist BioGeneration Ventures has named Keno Gutierrez as a partner and Wouter Verhoeven as a venture partner. The post BGV hires veteran pair to boost life science investment expertise first appeared on

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.